Peter W. McLaughlin

889 total citations
20 papers, 470 citations indexed

About

Peter W. McLaughlin is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Peter W. McLaughlin has authored 20 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Genetics. Recurrent topics in Peter W. McLaughlin's work include Lymphoma Diagnosis and Treatment (11 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Peter W. McLaughlin is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Peter W. McLaughlin collaborates with scholars based in United States and Switzerland. Peter W. McLaughlin's co-authors include Lillian M. Fuller, Fernando Cabanillas, John T. Manning, L B North, W S Velasquez, S.L. Tucker, Sundar Jagannath, Mark A. Chappell, R.J. Winfield and Peter L. Roberson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Peter W. McLaughlin

19 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter W. McLaughlin United States 9 265 198 96 95 89 20 470
Patti Cohen United States 9 388 1.5× 246 1.2× 61 0.6× 31 0.3× 151 1.7× 10 543
B. Bouchindhomme France 14 119 0.4× 164 0.8× 34 0.4× 240 2.5× 43 0.5× 27 599
Catherine Picard France 10 398 1.5× 78 0.4× 18 0.2× 69 0.7× 306 3.4× 16 799
Reinhardt J. Kau Germany 8 77 0.3× 238 1.2× 94 1.0× 76 0.8× 110 1.2× 9 689
Luciano Scandolaro Italy 13 475 1.8× 351 1.8× 177 1.8× 231 2.4× 70 0.8× 25 1.0k
V. Tison Italy 13 79 0.3× 125 0.6× 58 0.6× 170 1.8× 51 0.6× 26 474
Xuefei Jia United States 14 75 0.3× 194 1.0× 47 0.5× 256 2.7× 251 2.8× 41 589
Hitoshi Takashima Japan 12 27 0.1× 100 0.5× 40 0.4× 163 1.7× 39 0.4× 44 490
Feig Sa United States 19 361 1.4× 226 1.1× 111 1.2× 128 1.3× 88 1.0× 55 955
E Lopez Hänninen Germany 15 90 0.3× 308 1.6× 33 0.3× 269 2.8× 27 0.3× 24 701

Countries citing papers authored by Peter W. McLaughlin

Since Specialization
Citations

This map shows the geographic impact of Peter W. McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. McLaughlin more than expected).

Fields of papers citing papers by Peter W. McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. McLaughlin. The network helps show where Peter W. McLaughlin may publish in the future.

Co-authorship network of co-authors of Peter W. McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. McLaughlin. A scholar is included among the top collaborators of Peter W. McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. McLaughlin. Peter W. McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jaworski, E, M.M. Dominello, D.K. Heimburger, et al.. (2019). Contemporary Practice Patterns for Intact and Post-Operative Prostate Cancer: Results from a Statewide Collaborative. International Journal of Radiation Oncology*Biology*Physics. 105(1). E282–E282. 1 indexed citations
2.
Soni, Payal, et al.. (2017). Using Gradient Optimization in Place of Volumetric Constraints to Improve Rectal Dose Distribution During Dose-Escalated Radiation Therapy Planning for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). E723–E724. 1 indexed citations
3.
Mazloom, Ali, L. Jeffrey Medeiros, Peter W. McLaughlin, et al.. (2010). Marginal zone lymphomas. Cancer. 116(18). 4291–4298. 30 indexed citations
4.
McLaughlin, Peter W., et al.. (2006). 2227. International Journal of Radiation Oncology*Biology*Physics. 66(3). S336–S336. 2 indexed citations
5.
Roach, Mack, Vivian Weinberg, Katsuto Shinohara, et al.. (2005). Are Biochemical Control (bNED) Rates Following Permanent Prostate Implants (PPI) Consistent with Findings on Endorectal Magnetic Resonance Spectroscopy Imaging (eMRSI)?. International Journal of Radiation Oncology*Biology*Physics. 63. S36–S37. 2 indexed citations
7.
Younes, Anas, Barbara Pro, Michael J. Robertson, et al.. (2004). Phase II Clinical Trial of Interleukin-12 in Patients with Relapsed and Refractory Non-Hodgkin’s Lymphoma and Hodgkin’s Disease. Clinical Cancer Research. 10(16). 5432–5438. 74 indexed citations
8.
Esmaeli, Bita, Moloud Ahmadi, John T. Manning, Peter W. McLaughlin, & Lawrence E. Ginsberg. (2002). Clinical Presentation and Treatment of Secondary Orbital Lymphoma. Ophthalmic Plastic and Reconstructive Surgery. 18(4). 247–253. 31 indexed citations
9.
Ha, Chul S., Vivek S. Kavadi, Meletios Α. Dimopoulos, et al.. (1999). Hodgkin’s disease with lymphocyte predominance: long-term results based on current histopathologic criteria. International Journal of Radiation Oncology*Biology*Physics. 43(2). 329–334. 16 indexed citations
10.
Liao, Zhongxing, Chul S. Ha, Peter W. McLaughlin, et al.. (1998). Malt (mucosa associated lymphoid tissue) lymphoma with supradiaphragmatic presentation: Natural history and patterns of failure. International Journal of Radiation Oncology*Biology*Physics. 42(1). 343–343. 1 indexed citations
11.
Roberson, Peter L., et al.. (1997). Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants. International Journal of Radiation Oncology*Biology*Physics. 39(2). 341–346. 59 indexed citations
13.
Younes, Anas, Fernando Cabanillas, Peter W. McLaughlin, et al.. (1996). Preliminary experience with paclitaxel for the treatment of relapsed and refractory Hodgkin's disease. Annals of Oncology. 7(10). 1083–1085. 6 indexed citations
14.
Besa, Pelayo, Peter W. McLaughlin, James D. Cox, & Lillian M. Fuller. (1995). Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma. Cancer. 75(9). 2361–2367. 38 indexed citations
16.
Roberson, Peter L., et al.. (1995). 117 Impact of differences in ultrasound and CT volumes on treatment planning of permanent prostate implants. International Journal of Radiation Oncology*Biology*Physics. 32. 199–199. 6 indexed citations
17.
Murray, James L., Peter W. McLaughlin, Michael G. Rosenblum, et al.. (1994). PHASE I TRIAL OF ANTI-B4 BLOCKED RICIN (B4bR) GIVEN AS A 28 DAY CONTINUOUS INFUSION (CI). Journal of Immunotherapy. 16(3). 242–242. 2 indexed citations
18.
Chappell, Mark A. & Peter W. McLaughlin. (1993). Approach of modeling continuous turbine engine operation from startup to shutdown. Journal of Propulsion and Power. 9(3). 466–471. 33 indexed citations
19.
Jagannath, Sundar, W S Velasquez, S.L. Tucker, et al.. (1986). Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma.. Journal of Clinical Oncology. 4(6). 859–865. 153 indexed citations
20.
McLaughlin, Peter W., et al.. (1977). High frequency dynamic engine simulation. NASA STI Repository (National Aeronautics and Space Administration). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026